Senior Scientist, Degrader Antibody Conjugates Pharmacology

NURIX

San Francisco (CA)

On-site

USD 180,000 - 250,000

Full time

14 days+
Application generator

Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Nurix Therapeutics seeks a scientific leader to define and drive our in vitro screening and pharmacological characterization for Degrader Antibody Conjugates (DACs). This hands-on leadership role requires building assays, interpreting data, and guiding cross-functional teams from primary screening through candidate selection.

The ideal candidate will design, execute, and analyze cellular assays to characterize DAC activity, work with discovery biology, chemistry, and DMPK, and mentor scientists

Qualifications

  • PhD in Biochemistry, Pharmacology, Biology or related field with 4+ years of post-graduate experience, or MS with 8+ years in industry.
  • Demonstrated experience designing and executing in vitro pharmacology studies and screening cascades, preferably in ADC/DAC fields.
  • Leadership in a matrixed, cross-functional environment with ability to influence, align and drive teams.

Responsibilities

  • Design and build the in vitro pharmacology and screening framework for DACs and biologics from primary screening through mechanistic characterization.
  • Lead and influence a matrixed organization, partnering with discovery biology, chemistry, analytics, DMPK, and automation to advance programs.
  • Conduct and analyze cell-based assays to characterize DAC and biologic activity, including binding, engagement, and degradation measures.
  • Provide scientific judgment on assay strategy, data interpretation, and go/no-go recommendations.

Skills

in vitro pharmacology
ADC/DAC biology
cell culture
matrixed leadership
data interpretation
presentations
automation workflows

Education

PhD in Biochemistry
MS in Biology

Tools

Automation equipment
Liquid handling systems

Job description

Nurix Therapeutics seeks a scientific leader to define and drive our in vitro screening and pharmacological characterization for Degrader Antibody Conjugates (DACs). This hands-on leadership role requires building assays, interpreting data, and guiding cross-functional teams from primary screening through candidate selection.

The ideal candidate will design, execute, and analyze cellular assays to characterize DAC activity, work with discovery biology, chemistry, and DMPK, and mentor scientists

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Scientist, Degrader Antibody Conjugates (DAC) In Vitro
Senior Scientist, Degrader Antibody Conjugates (DAC) In Vitro

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 180,000 - 240,000
Senior Scientist, DAC In Vitro Pharmacology & Screening
Senior Scientist, DAC In Vitro Pharmacology & Screening

BioSpace • Brisbane (CA)

On-site
USD 162,000 - 174,000
Senior Scientist -Degrader Antibody Conjugate Cellular Pharmacology
Senior Scientist -Degrader Antibody Conjugate Cellular Pharmacology

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 180,000 - 240,000
Senior Scientist -Degrader Antibody Conjugate Cellular Pharmacology
Senior Scientist -Degrader Antibody Conjugate Cellular Pharmacology

Nurix Therapeutics • Brisbane (CA)

On-site
USD 127,000 - 143,000
Bioanalytical Scientist, DACs & LC-MS/MS PK/PD
Bioanalytical Scientist, DACs & LC-MS/MS PK/PD

Nurix Therapeutics • Brisbane (CA)

On-site
USD 90,000 - 130,000
Senior Scientist, Degrader Antibody Conjugate Cellular Pharmacology
Senior Scientist, Degrader Antibody Conjugate Cellular Pharmacology

NURIX • San Francisco (CA)

On-site
USD 180,000 - 250,000
Senior Scientist, Degrader Antibody Conjugate Cellular Pharmacology
Senior Scientist, Degrader Antibody Conjugate Cellular Pharmacology

BioSpace • Brisbane (CA)

On-site
USD 162,000 - 174,000
Scientist, Bioanalytical – Drug Antibody Conjugates (DACs)
Scientist, Bioanalytical – Drug Antibody Conjugates (DACs)

Nurix Therapeutics • Brisbane (CA)

On-site
USD 90,000 - 130,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 140,000 - 161,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Nurix Therapeutics • Brisbane (CA)

On-site
USD 140,000 - 161,000